Figure 3 | Scientific Reports

Figure 3

From: Robust combination of liver stereotactic body radiotherapy modulates pharmacokinetics of sorafenib toward preferable parameters

Figure 3

Mean bile concentration-time curve of Rho-123 in rats. Five groups were established: sham RT + Rho-123 (0.2 mg/kg, i.v.) (●); concurrent regimen, RT2Gy + Rho-123 (0.2 mg/kg, i.v.) 10 minutes (min) later (○); sequential regimen, RT2Gy + Rho-123 (0.2 mg/kg, i.v.) 24 hr later (▼); concurrent regimen, RT9Gy + Rho-123 (0.2 mg/kg, i.v.) 10 min later (△); and sequential regimen, RT9Gy + Rho-123 (0.2 mg/kg, i.v.) 24 hr later (■). The data are expressed as the mean ± SEM values (n = 6 per group).

Back to article page